The UK Defence and Security Accelerator (DASA) has launched a new competition to seek proposals for technologies that would help further develop bio-detection capability.

DASA aims to develop a fieldable system that would detect and report without users coming into close contact with hazardous and dangerous agents in the field.

The competition is seeking ideas that are focused on sensors and reporting mechanisms and that would be capable of remotely detecting the hazards as quickly as possible, thereby enabling front line users to safely avoid the threats.

In addition, technologies capable of detecting the hazard to a lower confidence level and then cue deployment of a high-confidence sensor could also be considered.

According to DASA, the current methods to detect, locate and report hazardous biological materials consume a lot of time and are labour intensive.

“According to DASA, the current methods to detect, locate and report hazardous biological materials consume a lot of time and are labour intensive.”

DASA is looking for proposals for proof-of-concept technologies above Technology Readiness Level (TRL) 2 Phase I. The competition’s Phase I has been allocated a total budget of up to £500k to fund around three to five projects.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the duration of the Phase I research projects is expected to be up to six months.

Additional funding is anticipated to be available for the future phases to further develop technologies to higher TRLs. The competition is scheduled to close on 7 November this year.

A biological agent is defined as a micro-organism, cell culture or human endoparasite, including any which have been genetically modified and might cause an infection, allergy or toxicity, or otherwise create a hazard to human health.